Simulations Plus (NASDAQ:SLP) Cut to Hold at Zacks Research

Simulations Plus (NASDAQ:SLP) was downgraded by equities researchers at Zacks Research from a “strong-buy” rating to a “hold” rating in a report released on Monday,Zacks.com reports.

Several other analysts also recently commented on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Simulations Plus in a research report on Wednesday, October 8th. KeyCorp reissued a “sector weight” rating on shares of Simulations Plus in a research report on Wednesday, October 29th. TD Cowen reaffirmed a “hold” rating on shares of Simulations Plus in a research report on Thursday, January 8th. BTIG Research downgraded Simulations Plus from a “buy” rating to a “neutral” rating in a research note on Thursday, December 18th. Finally, Citigroup reissued a “market perform” rating on shares of Simulations Plus in a report on Tuesday, January 6th. Three equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $25.00.

Simulations Plus Stock Down 8.2%

SLP stock opened at $15.40 on Monday. The business has a 50 day moving average of $18.99 and a 200 day moving average of $16.57. The firm has a market cap of $310.31 million, a PE ratio of -4.81 and a beta of 1.12. Simulations Plus has a twelve month low of $12.39 and a twelve month high of $37.67.

Simulations Plus (NASDAQ:SLP) last released its earnings results on Thursday, January 8th. The technology company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.05). Simulations Plus had a positive return on equity of 14.02% and a negative net margin of 81.66%.The company had revenue of $18.42 million during the quarter, compared to the consensus estimate of $18.05 million. During the same period last year, the firm posted $0.17 earnings per share. On average, research analysts expect that Simulations Plus will post 1.09 earnings per share for the current fiscal year.

Institutional Trading of Simulations Plus

Large investors have recently modified their holdings of the company. Tributary Capital Management LLC grew its stake in shares of Simulations Plus by 214.7% during the 3rd quarter. Tributary Capital Management LLC now owns 1,136,980 shares of the technology company’s stock valued at $17,134,000 after purchasing an additional 775,704 shares during the period. First Light Asset Management LLC lifted its stake in shares of Simulations Plus by 115.0% in the 3rd quarter. First Light Asset Management LLC now owns 767,760 shares of the technology company’s stock worth $11,570,000 after purchasing an additional 410,603 shares during the period. Stephens Investment Management Group LLC purchased a new position in shares of Simulations Plus in the second quarter worth approximately $4,687,000. Herald Investment Management Ltd bought a new stake in Simulations Plus during the third quarter valued at approximately $3,016,000. Finally, Squarepoint Ops LLC grew its position in Simulations Plus by 522.1% during the third quarter. Squarepoint Ops LLC now owns 220,103 shares of the technology company’s stock valued at $3,317,000 after buying an additional 184,725 shares during the period. Institutional investors own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.